Loading organizations...
Loading organizations...
Therapeutics company focused on treating aggressive cancers.
Trogenix has raised $94.1M across 1 funding round.
Trogenix has raised $94.1M in total across 1 funding round.
Trogenix has raised $94.1M in total across 1 funding round.
Trogenix's investors include Max Bautin, Calculus Capital, Iain Foulkes, Eli Lilly and Company, LongeVC, Meltwind, National Brain Tumor Society.
Trogenix has raised $94.1M across 1 funding round. Most recently, it raised $94.1M Series A in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 6, 2025 | $94.1M Series A | Max Bautin | Calculus Capital, Iain Foulkes, Eli Lilly and Company, LongeVC, Meltwind, National Brain Tumor Society |